HUSSMAN STRATEGIC ADVISORS, INC. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$255,192
-56.2%
12,4000.0%0.05%
-54.2%
Q2 2023$583,048
-46.6%
12,400
-52.3%
0.11%
-37.4%
Q1 2023$1,090,960
+10.0%
26,0000.0%0.17%
+5.6%
Q4 2022$991,640
-2.6%
26,0000.0%0.16%
-8.0%
Q3 2022$1,018,000
+21.2%
26,0000.0%0.18%
+21.4%
Q2 2022$840,000
-2.4%
26,0000.0%0.14%
-13.2%
Q1 2022$861,000
-22.2%
26,0000.0%0.17%
-31.3%
Q4 2021$1,106,000
-66.5%
26,000
-65.1%
0.24%
-66.6%
Q3 2021$3,297,000
-22.0%
74,4000.0%0.73%
-17.0%
Q2 2021$4,227,00074,4000.88%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 181,650$15,715,0007.17%
GREAT POINT PARTNERS LLC 454,417$39,312,0006.38%
ACUTA CAPITAL PARTNERS, LLC 255,800$22,129,0006.02%
Integral Health Asset Management, LLC 195,000$16,869,0005.02%
DAFNA Capital Management LLC 181,306$15,685,0004.67%
Boxer Capital, LLC 1,094,000$94,642,0003.04%
Palo Alto Investors LP 590,200$51,058,0002.68%
Bellevue Group AG 1,567,504$135,604,0001.55%
Aristotle Atlantic Partners, LLC 160,805$13,911,0001.07%
JGP Global Gestao de Recursos Ltda. 2,618$226,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders